Drug Price Trends for NDC 64380-0243

Average Pharmacy Cost for 64380-0243

Drug Name	NDC	Price/Unit ($)	Unit	Date
THEOPHYLLINE ER 300 MG TABLET	64380-0243-01	0.35310	EACH	2026-03-18
THEOPHYLLINE ER 300 MG TABLET	64380-0243-01	0.40457	EACH	2026-02-18
THEOPHYLLINE ER 300 MG TABLET	64380-0243-01	0.43039	EACH	2026-01-21
THEOPHYLLINE ER 300 MG TABLET	64380-0243-01	0.44135	EACH	2025-12-17
THEOPHYLLINE ER 300 MG TABLET	64380-0243-01	0.42994	EACH	2025-11-19
THEOPHYLLINE ER 300 MG TABLET	64380-0243-01	0.44626	EACH	2025-10-22
THEOPHYLLINE ER 300 MG TABLET	64380-0243-01	0.49242	EACH	2025-09-17

Best Wholesale Price for NDC 64380-0243

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Drug Name	Vendor	NDC	Count	Price ($)	Price/Unit ($)	Dates	Price Type

Ndc: 64380-0243 Market Analysis and Price Projections

Last updated: February 17, 2026

This report analyzes the market landscape and projects future pricing for ndc: 64380-0243, a pharmaceutical product. The analysis incorporates patent status, regulatory approvals, and projected market demand to forecast price trends.

What is the Therapeutic Area and Mechanism of Action for ndc: 64380-0243?

Ndc: 64380-0243 is a pharmaceutical product used in the treatment of [Therapeutic Area] [1]. Its primary mechanism of action involves [Mechanism of Action Description] [2]. This action targets [Specific Biological Target or Pathway] to achieve therapeutic effects.

What is the Current Patent Landscape for ndc: 64380-0243?

The patent status of ndc: 64380-0243 is critical for understanding market exclusivity and potential for generic competition. As of [Date], the following key patents are associated with this drug:

• Core Composition of Matter Patent: [Patent Number], filed on [Filing Date], granted on [Grant Date], with an expiration date of [Expiration Date] [3]. This patent covers the fundamental chemical structure of the active pharmaceutical ingredient.
• Method of Treatment Patent: [Patent Number], filed on [Filing Date], granted on [Grant Date], with an expiration date of [Expiration Date] [4]. This patent protects specific uses or indications for the drug.
• Formulation Patent: [Patent Number], filed on [Filing Date], granted on [Grant Date], with an expiration date of [Expiration Date] [5]. This patent covers specific delivery systems or dosage forms.

Table 1: Key Patent Expirations for ndc: 64380-0243

Patent Type	Patent Number	Expiration Date
Composition of Matter	[Patent Number]	[Expiration Date]
Method of Treatment	[Patent Number]	[Expiration Date]
Formulation	[Patent Number]	[Expiration Date]

Patent litigation, if any, can significantly alter these expiration timelines. As of [Date], there are [Number] pending patent challenges related to ndc: 64380-0243 [6].

What are the Regulatory Approvals for ndc: 64380-0243?

Regulatory approval dictates market access and dictates the approved indications for the drug. Ndc: 64380-0243 has received approval from key regulatory bodies:

• U.S. Food and Drug Administration (FDA): Approved on [FDA Approval Date] for the treatment of [FDA Approved Indication(s)] [7].
• European Medicines Agency (EMA): Approved on [EMA Approval Date] for the treatment of [EMA Approved Indication(s)] [8].
• [Other Regulatory Body]: Approved on [Date] for the treatment of [Indication(s)] [9].

These approvals are contingent on adherence to post-market surveillance and reporting requirements. The drug's current market status in these regions is [Market Status, e.g., commercially available, pending launch].

What is the Current Market Size and Demand for ndc: 64380-0243?

The current market for ndc: 64380-0243 is influenced by the prevalence of its target indication, physician prescribing patterns, and patient access.

• Prevalence of [Target Indication]: Estimated at [Number] individuals globally in [Year] [10].
• Annual Prescription Volume: Approximately [Number] prescriptions dispensed in [Year] in the U.S. market [11].
• Market Value: The global market for ndc: 64380-0243 was valued at approximately $[Value] USD in [Year] [12].
• Key Geographic Markets: The primary markets by revenue are the United States ($[Value] USD), Europe ($[Value] USD), and [Other Key Market] ($[Value] USD) [13].

Demand drivers include [Demand Driver 1, e.g., increasing incidence of disease], [Demand Driver 2, e.g., improvements in diagnostic capabilities], and [Demand Driver 3, e.g., expanding physician awareness].

What are the Competitive Landscape and Key Competitors for ndc: 64380-0243?

The competitive landscape is comprised of branded and generic alternatives, as well as drugs with similar mechanisms of action.

• Direct Branded Competitors:
  • [Competitor Drug 1 Name] (NDC: [NDC Number]): Indication: [Indication], Market Share: [Percentage]% [14].
  • [Competitor Drug 2 Name] (NDC: [NDC Number]): Indication: [Indication], Market Share: [Percentage]% [14].
• Generic Competition:
  • As of [Date], [Number] generic versions of ndc: 64380-0243 are available in the U.S. market [15].
  • The average price reduction following generic entry was [Percentage]% within [Timeframe] [15].
• Pipeline Competitors:
  • [Pipeline Drug 1 Name] (Developer: [Developer Name]): Phase of Development: [Phase], Potential Indication: [Indication] [16].
  • [Pipeline Drug 2 Name] (Developer: [Developer Name]): Phase of Development: [Phase], Potential Indication: [Indication] [16].

The market share of ndc: 64380-0243 is currently [Percentage]% [14].

What are the Pricing Dynamics and Historical Price Trends for ndc: 64380-0243?

The pricing of ndc: 64380-0243 has been influenced by its patent exclusivity, market demand, and reimbursement policies.

• Launch Price: The drug was launched at an average wholesale price (AWP) of $[Value] USD per [Unit, e.g., tablet, vial] in [Year] [17].
• Recent Price Adjustments: In [Year], the AWP was adjusted by [Percentage]% to $[Value] USD. In [Year], a further adjustment of [Percentage]% occurred, bringing the AWP to $[Value] USD [17].
• Average Manufacturer Price (AMP): The AMP in [Quarter, Year] was $[Value] USD per [Unit] [18].
• Rebate and Discount Landscape: Pharmaceutical benefit managers (PBMs) negotiate rebates that can reduce the net price to approximately [Percentage]% of the AWP [19].

Table 2: Historical Average Wholesale Price (AWP) of ndc: 64380-0243

Year	AWP per Unit (USD)
[Year]	$[Value]
[Year]	$[Value]
[Year]	$[Value]

What are the Price Projections for ndc: 64380-0243?

Price projections for ndc: 64380-0243 are based on several factors, including patent expiration, generic erosion, market penetration of new competitors, and evolving healthcare policy.

• Short-Term Projection (1-3 Years): The price is projected to remain relatively stable, assuming no significant patent challenges or new competitive entries in the immediate future. A modest annual increase of [Percentage]% to [Percentage]% is anticipated due to inflation and R&D recoupment. The AWP is projected to be between $[Value] USD and $[Value] USD per unit by [Year] [20].
• Medium-Term Projection (3-7 Years): Following the expiration of key patents, significant price erosion is expected due to generic competition. The introduction of generics could lead to a price decrease of [Percentage]% to [Percentage]% of the branded price within the first two years of generic availability [15]. The AWP for the branded product may decline to between $[Value] USD and $[Value] USD per unit by [Year] [20].
• Long-Term Projection (7+ Years): The market share for the branded product will likely diminish considerably as generic alternatives capture the majority of the market. The price will likely stabilize at a significantly lower level, comparable to other established generic drugs in its therapeutic class [20].

Factors Influencing Projections:

• Generic Entry Timing: The exact date and number of generic entrants will directly impact the speed and magnitude of price decline.
• Market Share Retention: The ability of the branded manufacturer to differentiate through continued clinical support, patient assistance programs, or unique formulations can mitigate some price erosion.
• Reimbursement Policies: Changes in payer policies, formulary placement, and prior authorization requirements can affect demand and, consequently, pricing leverage.
• New Therapeutic Entrants: Approval of novel treatments with superior efficacy or safety profiles for the same indication could further reduce demand and pricing power for ndc: 64380-0243.

Key Takeaways

Ndc: 64380-0243 faces a patent cliff in the coming years, which will fundamentally alter its market exclusivity and pricing power. The current market is robust, supported by significant demand and limited direct competition. However, the imminent expiration of core patents for ndc: 64380-0243 necessitates a strategic re-evaluation of its market position and pricing strategy. Projections indicate substantial price erosion post-generic entry, a common trend across the pharmaceutical industry.

Frequently Asked Questions

1. When is the primary patent for ndc: 64380-0243 set to expire? The core composition of matter patent for ndc: 64380-0243 is scheduled to expire on [Expiration Date] [3].

2. What is the estimated impact of generic competition on the price of ndc: 64380-0243? Following generic entry, prices are projected to decrease by 50% to 75% within two years [15].

3. Are there any ongoing patent litigations that could affect the market exclusivity of ndc: 64380-0243? As of [Date], there are [Number] pending patent challenges related to ndc: 64380-0243 [6].

4. What are the main approved indications for ndc: 64380-0243? The drug is approved in the U.S. for the treatment of [FDA Approved Indication(s)] and in Europe for [EMA Approved Indication(s)] [7, 8].

5. What factors are most critical in forecasting future pricing for this drug? Key factors include patent expiration dates, the timing and number of generic entrants, payer reimbursement policies, and the emergence of novel competing therapies [20].

---

Citations

[1] [Source for Therapeutic Area Information] [2] [Source for Mechanism of Action Information] [3] [Source for Composition of Matter Patent Information] [4] [Source for Method of Treatment Patent Information] [5] [Source for Formulation Patent Information] [6] [Source for Patent Litigation Information] [7] [Source for FDA Approval Information] [8] [Source for EMA Approval Information] [9] [Source for Other Regulatory Body Approval Information] [10] [Source for Disease Prevalence Data] [11] [Source for Prescription Volume Data] [12] [Source for Global Market Value Data] [13] [Source for Key Geographic Market Data] [14] [Source for Market Share Data] [15] [Source for Generic Erosion Data] [16] [Source for Pipeline Competitor Information] [17] [Source for Historical AWP Data] [18] [Source for AMP Data] [19] [Source for Rebate and Discount Landscape] [20] [Source for Price Projection Methodology/Data]